Validity of Danish register diagnoses of myocardial infarction and stroke against experts in people with screen-detected diabetes.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
22 Feb 2019
Historique:
received: 09 11 2018
accepted: 15 02 2019
entrez: 24 2 2019
pubmed: 24 2 2019
medline: 9 4 2019
Statut: epublish

Résumé

Administrative patient registers are often used to estimate morbidity in epidemiological studies. The validity of register data is thus important. This study aims to assess the positive predictive value of myocardial infarction and stroke registered in the Danish National Patient Register, and to examine the association between cardiovascular risk factors and cardiovascular disease based on register data or validated diagnoses in a well-defined diabetes population. We included 1533 individuals found with screen-detected type 2 diabetes in the ADDITION-Denmark study in 2001-2006. All individuals were followed for cardiovascular outcomes until the end of 2014. Hospital discharge codes for myocardial infarction and stroke were identified in the Danish National Patient Register. Hospital medical records and other clinically relevant information were collected and an independent adjudication committee evaluated all possible events. The positive predictive value for myocardial infarction and stroke were calculated as the proportion of cases recorded in the Danish National Patient Register confirmed by the adjudication committee. The positive predictive value was 75% (95% CI: 64;84) for MI and 70% (95% CI: 54;80) for stroke. The association between cardiovascular risk factors and incident cardiovascular disease did not depend on using register-based or verified diagnoses. However, a tendency was seen towards stronger associations when using verified diagnoses. Our results show that studies using only register-based diagnoses are likely to misclassify cardiovascular outcomes. Moreover, the results suggest that the magnitude of associations between cardiovascular risk factors and cardiovascular outcomes may be underestimated when using register-based diagnoses.

Sections du résumé

BACKGROUND BACKGROUND
Administrative patient registers are often used to estimate morbidity in epidemiological studies. The validity of register data is thus important. This study aims to assess the positive predictive value of myocardial infarction and stroke registered in the Danish National Patient Register, and to examine the association between cardiovascular risk factors and cardiovascular disease based on register data or validated diagnoses in a well-defined diabetes population.
METHODS METHODS
We included 1533 individuals found with screen-detected type 2 diabetes in the ADDITION-Denmark study in 2001-2006. All individuals were followed for cardiovascular outcomes until the end of 2014. Hospital discharge codes for myocardial infarction and stroke were identified in the Danish National Patient Register. Hospital medical records and other clinically relevant information were collected and an independent adjudication committee evaluated all possible events. The positive predictive value for myocardial infarction and stroke were calculated as the proportion of cases recorded in the Danish National Patient Register confirmed by the adjudication committee.
RESULTS RESULTS
The positive predictive value was 75% (95% CI: 64;84) for MI and 70% (95% CI: 54;80) for stroke. The association between cardiovascular risk factors and incident cardiovascular disease did not depend on using register-based or verified diagnoses. However, a tendency was seen towards stronger associations when using verified diagnoses.
CONCLUSIONS CONCLUSIONS
Our results show that studies using only register-based diagnoses are likely to misclassify cardiovascular outcomes. Moreover, the results suggest that the magnitude of associations between cardiovascular risk factors and cardiovascular outcomes may be underestimated when using register-based diagnoses.

Identifiants

pubmed: 30795763
doi: 10.1186/s12889-019-6549-z
pii: 10.1186/s12889-019-6549-z
pmc: PMC6387546
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

228

Subventions

Organisme : Novo Nordisk Foundation Challenge Programme
ID : grant NNF14OC0011633

Références

Dan Med Bull. 1999 Jun;46(3):263-8
pubmed: 10421985
Int J Obes Relat Metab Disord. 2000 Sep;24 Suppl 3:S6-11
pubmed: 11063279
J Clin Epidemiol. 2002 Jun;55(6):602-7
pubmed: 12063102
J Clin Epidemiol. 2003 Feb;56(2):124-30
pubmed: 12654406
Am J Med. 2007 Jan;120(1):47-53
pubmed: 17208079
Neuroepidemiology. 2007;28(3):150-4
pubmed: 17478969
J Clin Epidemiol. 2009 Feb;62(2):188-94
pubmed: 18722087
BMC Med Res Methodol. 2011 May 28;11:83
pubmed: 21619668
Lancet. 2011 Jul 9;378(9786):156-67
pubmed: 21705063
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
BMJ Open. 2013 Jun 20;3(6):null
pubmed: 23794587
Clin Epidemiol. 2013 Dec 23;6:27-36
pubmed: 24399886
PLoS One. 2015 Aug 20;10(8):e0135834
pubmed: 26292280
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
BMJ Open. 2016 Nov 18;6(11):e012832
pubmed: 27864249

Auteurs

Else-Marie Dalsgaard (EM)

Department of Public Health, Aarhus University, Bartholins allé 2, DK-8000, Aarhus C, Denmark. emdl@ph.au.dk.

Daniel Rinse Witte (DR)

Department of Public Health, Aarhus University and Danish Diabetes Academy, Odense, Denmark.

Morten Charles (M)

Department of Public Health, Aarhus University, Bartholins allé 2, DK-8000, Aarhus C, Denmark.

Marit Eika Jørgensen (ME)

Steno Diabetes Center Copenhagen, The Capital Region of Denmark, Copenhagen, Denmark.

Torsten Lauritzen (T)

Department of Public Health, Aarhus University, Bartholins allé 2, DK-8000, Aarhus C, Denmark.

Annelli Sandbæk (A)

Department of Public Health, Aarhus University and Steno Diabetes Center, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH